Emerging drug therapies in Huntington's disease

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.14, Iss.2, 2009-06, pp. : 273-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging chemotherapeutic strategies for Huntington’s disease

By Ryu Hoon Ferrante Robert J

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 345-363

Informa Healthcare

Access to resources Recommend Favorite

From Preclinical to Clinical Trials: An Update on Potential Therapies for Huntington’s Disease

By S. Brocardo Patricia M. Gil-Mohapel Joana

Current Psychopharmacology, Vol. 2, Iss. 2, 2013-05 ,pp. : 113-131

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drug therapies for benign prostatic hyperplasia

By Bullock Travis L Andriole Jr Gerald L

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 111-123

Informa Healthcare

Access to resources Recommend Favorite

Drug Treatment of Obesity: Established and Emerging Therapies

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 6, 2009-06 ,pp. : 664-673

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapies for graft-versus-host disease

By Jacobsohn David A

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 323-338

Informa Healthcare

Access to resources Recommend Favorite